Skip Navigation

European Heart Journal 2001 22(3):192-195; doi:10.1053/euhj.2000.2393
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tavazzi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tavazzi, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Towards a more precise definition of heart failure aetiology

L. Tavazzi

Department of Cardiology, IRCCS Policlinico San Matteo, Pavia, Italy

References

  1. Kannel WB, Ho K, Thom K. Changing epidemiological features of cardiac failure. Eur Hear J. 1994;72:S3–9
  2. Levy D, Larson MG, Vasan RS. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–1562[Abstract/Free Full Text]
  3. Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J. 1991;121:1852–1853[CrossRef][Web of Science][Medline]
  4. Anderson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J. 1993;126:632–640[CrossRef][Web of Science][Medline]
  5. Eur Heart J. 1997;18:1457–1464[Abstract/Free Full Text]
  6. Schmieder RE, Martus P, Klingbell A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double blind studies. JAMA. 1996;275:1507–1513[Abstract/Free Full Text]
  7. Levi D. Deaths rates from coronary disease: progress and puzzling paradox. N Engl J Med. 1998;339:915–917[Free Full Text]
  8. Murray CJL, Lopez A. Mortality by cause of eight regions of the world: global burden of disease study. Lancet. 1997;349:1269–1276[CrossRef][Web of Science][Medline]
  9. Cowie MR, Mosterd A, Wood DA. The epidemiology of heart failure. Eur Heart J. 1997;18:208–225[Free Full Text]
  10. Opasich C, Tavazzi L. Clinical epidemiology of heart failure. Congestive Heart Failure. 1999;5:260–269
  11. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI 2 data-base. Circulation. 1993;88:416–429[Abstract/Free Full Text]
  12. GISSI-3 Investigators
  13. Maggioni AP, Tavazzi L, Fabbri G. Epidemiology of postinfarction risk stratification strategies in a country with a low volume of revascularization procedures. Eur Heart J. 1998;19:1784–1794[Abstract/Free Full Text]
  14. Fox KF, Cowie MR, Wood DA. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J. 2000;21:228–236
  15. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995;26:1565–1574[Abstract]
  16. Tavazzi L, Tarantini M, Gorini M. Heart failure with preserved systolic ventricular function: clinical and prognostic data from the Italian Network on Congestive Heart Failure (IN-CHF) database. Circulation. 1999;100:I:23
  17. Gheorghiade M, Bonow RO. Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation. 1998;97:282–289[Free Full Text]
  18. Opasich C, Tavazzi L, Lucci D. Comparison of 1-year outcome in women vs men with chronic congestive heart failure. Am J Cardiol. 2000;86:353–357[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
J. Kim, D. R. Jacobs Jr., R. V. Luepker, E. Shahar, K. L. Margolis, and M. P. Becker
Prognostic Value of a Novel Classification Scheme for Heart Failure: The Minnesota Heart Failure Criteria
Am. J. Epidemiol., July 15, 2006; 164(2): 184 - 193.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
F. Ceia, C. Fonseca, T. Mota, H. Morais, F. Matias, C. Costa, and A. G. Oliveira
Aetiology, comorbidity and drug therapy of chronic heart failure in the real world: the EPICA substudy
Eur J Heart Fail, October 1, 2004; 6(6): 801 - 806.
[Abstract] [Full Text] [PDF]


This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tavazzi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tavazzi, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?